1 Study Coverage
1.1 Bipolar Disorder Therapeutics Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Olanzapine (Zyprexa)
1.2.3 Quetiapine (Seroquel)
1.2.4 Risperidone (Risperdal)
1.2.5 Ariprazole (Abilify)
1.2.6 Ziprasidone (Geodon)
1.2.7 Clozapine (Clozaril)
1.3 Market by Application
1.3.1 Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 lumateperone
1.3.3 Central Nervous System (CNS) Disorders
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bipolar Disorder Therapeutics Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Bipolar Disorder Therapeutics Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Bipolar Disorder Therapeutics Drugs Sales by Region
2.4.1 Global Bipolar Disorder Therapeutics Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Bipolar Disorder Therapeutics Drugs by Region (2023-2028)
2.5 Global Bipolar Disorder Therapeutics Drugs Revenue by Region
2.5.1 Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2017-2022)
2.5.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bipolar Disorder Therapeutics Drugs Sales by Manufacturers
3.1.1 Global Top Bipolar Disorder Therapeutics Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bipolar Disorder Therapeutics Drugs in 2021
3.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Manufacturers
3.2.1 Global Bipolar Disorder Therapeutics Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Bipolar Disorder Therapeutics Drugs Revenue in 2021
3.3 Global Bipolar Disorder Therapeutics Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bipolar Disorder Therapeutics Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bipolar Disorder Therapeutics Drugs Sales by Type
4.1.1 Global Bipolar Disorder Therapeutics Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Bipolar Disorder Therapeutics Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2017-2028)
4.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Type
4.2.1 Global Bipolar Disorder Therapeutics Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Bipolar Disorder Therapeutics Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Bipolar Disorder Therapeutics Drugs Price by Type
4.3.1 Global Bipolar Disorder Therapeutics Drugs Price by Type (2017-2022)
4.3.2 Global Bipolar Disorder Therapeutics Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Bipolar Disorder Therapeutics Drugs Sales by Application
5.1.1 Global Bipolar Disorder Therapeutics Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Bipolar Disorder Therapeutics Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2028)
5.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Application
5.2.1 Global Bipolar Disorder Therapeutics Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Bipolar Disorder Therapeutics Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Bipolar Disorder Therapeutics Drugs Price by Application
5.3.1 Global Bipolar Disorder Therapeutics Drugs Price by Application (2017-2022)
5.3.2 Global Bipolar Disorder Therapeutics Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Bipolar Disorder Therapeutics Drugs Market Size by Type
6.1.1 North America Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2028)
6.1.2 North America Bipolar Disorder Therapeutics Drugs Revenue by Type (2017-2028)
6.2 North America Bipolar Disorder Therapeutics Drugs Market Size by Application
6.2.1 North America Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2028)
6.2.2 North America Bipolar Disorder Therapeutics Drugs Revenue by Application (2017-2028)
6.3 North America Bipolar Disorder Therapeutics Drugs Market Size by Country
6.3.1 North America Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2028)
6.3.2 North America Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Bipolar Disorder Therapeutics Drugs Market Size by Type
7.1.1 Europe Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2028)
7.1.2 Europe Bipolar Disorder Therapeutics Drugs Revenue by Type (2017-2028)
7.2 Europe Bipolar Disorder Therapeutics Drugs Market Size by Application
7.2.1 Europe Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2028)
7.2.2 Europe Bipolar Disorder Therapeutics Drugs Revenue by Application (2017-2028)
7.3 Europe Bipolar Disorder Therapeutics Drugs Market Size by Country
7.3.1 Europe Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2028)
7.3.2 Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bipolar Disorder Therapeutics Drugs Market Size by Type
8.1.1 Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Bipolar Disorder Therapeutics Drugs Market Size by Application
8.2.1 Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Bipolar Disorder Therapeutics Drugs Market Size by Region
8.3.1 Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Bipolar Disorder Therapeutics Drugs Market Size by Type
9.1.1 Latin America Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2028)
9.1.2 Latin America Bipolar Disorder Therapeutics Drugs Revenue by Type (2017-2028)
9.2 Latin America Bipolar Disorder Therapeutics Drugs Market Size by Application
9.2.1 Latin America Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2028)
9.2.2 Latin America Bipolar Disorder Therapeutics Drugs Revenue by Application (2017-2028)
9.3 Latin America Bipolar Disorder Therapeutics Drugs Market Size by Country
9.3.1 Latin America Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2028)
9.3.2 Latin America Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Bipolar Disorder Therapeutics Drugs Market Size by Type
10.1.1 Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Bipolar Disorder Therapeutics Drugs Market Size by Application
10.2.1 Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Bipolar Disorder Therapeutics Drugs Market Size by Country
10.3.1 Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AstraZeneca Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Allergan
11.2.1 Allergan Corporation Information
11.2.2 Allergan Overview
11.2.3 Allergan Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Allergan Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Allergan Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Overview
11.3.3 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 GSK
11.4.1 GSK Corporation Information
11.4.2 GSK Overview
11.4.3 GSK Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 GSK Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GSK Recent Developments
11.5 Janssen
11.5.1 Janssen Corporation Information
11.5.2 Janssen Overview
11.5.3 Janssen Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Janssen Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Janssen Recent Developments
11.6 AbbVie
11.6.1 AbbVie Corporation Information
11.6.2 AbbVie Overview
11.6.3 AbbVie Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 AbbVie Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 AbbVie Recent Developments
11.7 Youdim
11.7.1 Youdim Corporation Information
11.7.2 Youdim Overview
11.7.3 Youdim Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Youdim Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Youdim Recent Developments
11.8 Delpor
11.8.1 Delpor Corporation Information
11.8.2 Delpor Overview
11.8.3 Delpor Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Delpor Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Delpor Recent Developments
11.9 Lundbeck
11.9.1 Lundbeck Corporation Information
11.9.2 Lundbeck Overview
11.9.3 Lundbeck Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Lundbeck Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Lundbeck Recent Developments
11.10 Intra-Cellular Therapies
11.10.1 Intra-Cellular Therapies Corporation Information
11.10.2 Intra-Cellular Therapies Overview
11.10.3 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Intra-Cellular Therapies Recent Developments
11.11 Novartis Pharmaceuticals Corporation
11.11.1 Novartis Pharmaceuticals Corporation Corporation Information
11.11.2 Novartis Pharmaceuticals Corporation Overview
11.11.3 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Novartis Pharmaceuticals Corporation Recent Developments
11.12 Noven Pharmaceuticals
11.12.1 Noven Pharmaceuticals Corporation Information
11.12.2 Noven Pharmaceuticals Overview
11.12.3 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Noven Pharmaceuticals Recent Developments
11.13 Otsuka
11.13.1 Otsuka Corporation Information
11.13.2 Otsuka Overview
11.13.3 Otsuka Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Otsuka Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Otsuka Recent Developments
11.14 Pfizer
11.14.1 Pfizer Corporation Information
11.14.2 Pfizer Overview
11.14.3 Pfizer Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Pfizer Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Pfizer Recent Developments
11.15 Reviva Pharmaceuticals
11.15.1 Reviva Pharmaceuticals Corporation Information
11.15.2 Reviva Pharmaceuticals Overview
11.15.3 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Reviva Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bipolar Disorder Therapeutics Drugs Industry Chain Analysis
12.2 Bipolar Disorder Therapeutics Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bipolar Disorder Therapeutics Drugs Production Mode & Process
12.4 Bipolar Disorder Therapeutics Drugs Sales and Marketing
12.4.1 Bipolar Disorder Therapeutics Drugs Sales Channels
12.4.2 Bipolar Disorder Therapeutics Drugs Distributors
12.5 Bipolar Disorder Therapeutics Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bipolar Disorder Therapeutics Drugs Industry Trends
13.2 Bipolar Disorder Therapeutics Drugs Market Drivers
13.3 Bipolar Disorder Therapeutics Drugs Market Challenges
13.4 Bipolar Disorder Therapeutics Drugs Market Restraints
14 Key Findings in The Global Bipolar Disorder Therapeutics Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Olanzapine (Zyprexa)
Table 3. Major Manufacturers of Quetiapine (Seroquel)
Table 4. Major Manufacturers of Risperidone (Risperdal)
Table 5. Major Manufacturers of Ariprazole (Abilify)
Table 6. Major Manufacturers of Ziprasidone (Geodon)
Table 7. Major Manufacturers of Clozapine (Clozaril)
Table 8. Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Bipolar Disorder Therapeutics Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 10. Global Bipolar Disorder Therapeutics Drugs Sales by Region (2017-2022) & (K Units)
Table 11. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2017-2022)
Table 12. Global Bipolar Disorder Therapeutics Drugs Sales by Region (2023-2028) & (K Units)
Table 13. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2023-2028)
Table 14. Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 15. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Table 16. Global Bipolar Disorder Therapeutics Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 17. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2023-2028)
Table 18. Global Bipolar Disorder Therapeutics Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 19. Global Bipolar Disorder Therapeutics Drugs Sales Share by Manufacturers (2017-2022)
Table 20. Global Bipolar Disorder Therapeutics Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 21. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Manufacturers (2017-2022)
Table 22. Bipolar Disorder Therapeutics Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
Table 23. Global Bipolar Disorder Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Bipolar Disorder Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bipolar Disorder Therapeutics Drugs as of 2021)
Table 25. Bipolar Disorder Therapeutics Drugs Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Bipolar Disorder Therapeutics Drugs Product Offered
Table 27. Date of Manufacturers Enter into Bipolar Disorder Therapeutics Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
Table 30. Global Bipolar Disorder Therapeutics Drugs Sales by Type (2023-2028) & (K Units)
Table 31. Global Bipolar Disorder Therapeutics Drugs Sales Share by Type (2017-2022)
Table 32. Global Bipolar Disorder Therapeutics Drugs Sales Share by Type (2023-2028)
Table 33. Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 34. Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 35. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Type (2017-2022)
Table 36. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Type (2023-2028)
Table 37. Bipolar Disorder Therapeutics Drugs Price by Type (2017-2022) & (USD/Unit)
Table 38. Global Bipolar Disorder Therapeutics Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
Table 39. Global Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2022) & (K Units)
Table 40. Global Bipolar Disorder Therapeutics Drugs Sales by Application (2023-2028) & (K Units)
Table 41. Global Bipolar Disorder Therapeutics Drugs Sales Share by Application (2017-2022)
Table 42. Global Bipolar Disorder Therapeutics Drugs Sales Share by Application (2023-2028)
Table 43. Global Bipolar Disorder Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 44. Global Bipolar Disorder Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 45. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Application (2017-2022)
Table 46. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Application (2023-2028)
Table 47. Bipolar Disorder Therapeutics Drugs Price by Application (2017-2022) & (USD/Unit)
Table 48. Global Bipolar Disorder Therapeutics Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
Table 49. North America Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
Table 50. North America Bipolar Disorder Therapeutics Drugs Sales by Type (2023-2028) & (K Units)
Table 51. North America Bipolar Disorder Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 52. North America Bipolar Disorder Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 53. North America Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2022) & (K Units)
Table 54. North America Bipolar Disorder Therapeutics Drugs Sales by Application (2023-2028) & (K Units)
Table 55. North America Bipolar Disorder Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 56. North America Bipolar Disorder Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 57. North America Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 58. North America Bipolar Disorder Therapeutics Drugs Sales by Country (2023-2028) & (K Units)
Table 59. North America Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 60. North America Bipolar Disorder Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 61. Europe Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
Table 62. Europe Bipolar Disorder Therapeutics Drugs Sales by Type (2023-2028) & (K Units)
Table 63. Europe Bipolar Disorder Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 64. Europe Bipolar Disorder Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 65. Europe Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2022) & (K Units)
Table 66. Europe Bipolar Disorder Therapeutics Drugs Sales by Application (2023-2028) & (K Units)
Table 67. Europe Bipolar Disorder Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 68. Europe Bipolar Disorder Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 69. Europe Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 70. Europe Bipolar Disorder Therapeutics Drugs Sales by Country (2023-2028) & (K Units)
Table 71. Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 72. Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 73. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
Table 74. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Type (2023-2028) & (K Units)
Table 75. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 76. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 77. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2022) & (K Units)
Table 78. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Application (2023-2028) & (K Units)
Table 79. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 80. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 81. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Region (2017-2022) & (K Units)
Table 82. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Region (2023-2028) & (K Units)
Table 83. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 84. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 85. Latin America Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
Table 86. Latin America Bipolar Disorder Therapeutics Drugs Sales by Type (2023-2028) & (K Units)
Table 87. Latin America Bipolar Disorder Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 88. Latin America Bipolar Disorder Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 89. Latin America Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2022) & (K Units)
Table 90. Latin America Bipolar Disorder Therapeutics Drugs Sales by Application (2023-2028) & (K Units)
Table 91. Latin America Bipolar Disorder Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 92. Latin America Bipolar Disorder Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 93. Latin America Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 94. Latin America Bipolar Disorder Therapeutics Drugs Sales by Country (2023-2028) & (K Units)
Table 95. Latin America Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 96. Latin America Bipolar Disorder Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Type (2017-2022) & (K Units)
Table 98. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Type (2023-2028) & (K Units)
Table 99. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Application (2017-2022) & (K Units)
Table 102. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Application (2023-2028) & (K Units)
Table 103. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Country (2017-2022) & (K Units)
Table 106. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Country (2023-2028) & (K Units)
Table 107. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 109. AstraZeneca Corporation Information
Table 110. AstraZeneca Description and Major Businesses
Table 111. AstraZeneca Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. AstraZeneca Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. AstraZeneca Recent Developments
Table 114. Allergan Corporation Information
Table 115. Allergan Description and Major Businesses
Table 116. Allergan Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Allergan Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Allergan Recent Developments
Table 119. Bristol-Myers Squibb Corporation Information
Table 120. Bristol-Myers Squibb Description and Major Businesses
Table 121. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Bristol-Myers Squibb Recent Developments
Table 124. GSK Corporation Information
Table 125. GSK Description and Major Businesses
Table 126. GSK Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. GSK Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. GSK Recent Developments
Table 129. Janssen Corporation Information
Table 130. Janssen Description and Major Businesses
Table 131. Janssen Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. Janssen Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Janssen Recent Developments
Table 134. AbbVie Corporation Information
Table 135. AbbVie Description and Major Businesses
Table 136. AbbVie Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. AbbVie Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. AbbVie Recent Developments
Table 139. Youdim Corporation Information
Table 140. Youdim Description and Major Businesses
Table 141. Youdim Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Youdim Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Youdim Recent Developments
Table 144. Delpor Corporation Information
Table 145. Delpor Description and Major Businesses
Table 146. Delpor Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 147. Delpor Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Delpor Recent Developments
Table 149. Lundbeck Corporation Information
Table 150. Lundbeck Description and Major Businesses
Table 151. Lundbeck Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 152. Lundbeck Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Lundbeck Recent Developments
Table 154. Intra-Cellular Therapies Corporation Information
Table 155. Intra-Cellular Therapies Description and Major Businesses
Table 156. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 157. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Intra-Cellular Therapies Recent Developments
Table 159. Novartis Pharmaceuticals Corporation Corporation Information
Table 160. Novartis Pharmaceuticals Corporation Description and Major Businesses
Table 161. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 162. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Novartis Pharmaceuticals Corporation Recent Developments
Table 164. Noven Pharmaceuticals Corporation Information
Table 165. Noven Pharmaceuticals Description and Major Businesses
Table 166. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 167. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Noven Pharmaceuticals Recent Developments
Table 169. Otsuka Corporation Information
Table 170. Otsuka Description and Major Businesses
Table 171. Otsuka Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 172. Otsuka Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 173. Otsuka Recent Developments
Table 174. Pfizer Corporation Information
Table 175. Pfizer Description and Major Businesses
Table 176. Pfizer Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 177. Pfizer Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 178. Pfizer Recent Developments
Table 179. Reviva Pharmaceuticals Corporation Information
Table 180. Reviva Pharmaceuticals Description and Major Businesses
Table 181. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 182. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 183. Reviva Pharmaceuticals Recent Developments
Table 184. Key Raw Materials Lists
Table 185. Raw Materials Key Suppliers Lists
Table 186. Bipolar Disorder Therapeutics Drugs Distributors List
Table 187. Bipolar Disorder Therapeutics Drugs Customers List
Table 188. Bipolar Disorder Therapeutics Drugs Market Trends
Table 189. Bipolar Disorder Therapeutics Drugs Market Drivers
Table 190. Bipolar Disorder Therapeutics Drugs Market Challenges
Table 191. Bipolar Disorder Therapeutics Drugs Market Restraints
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Bipolar Disorder Therapeutics Drugs Product Picture
Figure 3. Global Bipolar Disorder Therapeutics Drugs Market Share by Type in 2021 & 2028
Figure 3. Olanzapine (Zyprexa) Product Picture
Figure 4. Quetiapine (Seroquel) Product Picture
Figure 5. Risperidone (Risperdal) Product Picture
Figure 6. Ariprazole (Abilify) Product Picture
Figure 7. Ziprasidone (Geodon) Product Picture
Figure 8. Clozapine (Clozaril) Product Picture
Figure 9. Global Bipolar Disorder Therapeutics Drugs Market Share by Application in 2021 & 2028
Figure 10. lumateperone
Figure 11. Central Nervous System (CNS) Disorders
Figure 12. Bipolar Disorder Therapeutics Drugs Report Years Considered
Figure 13. Global Bipolar Disorder Therapeutics Drugs Sales 2017-2028 (K Units)
Figure 14. Global Bipolar Disorder Therapeutics Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Bipolar Disorder Therapeutics Drugs Revenue 2017-2028 (US$ Million)
Figure 16. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2017-2022)
Figure 18. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2023-2028)
Figure 19. North America Bipolar Disorder Therapeutics Drugs Sales YoY (2017-2028) & (K Units)
Figure 20. North America Bipolar Disorder Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Bipolar Disorder Therapeutics Drugs Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Bipolar Disorder Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Bipolar Disorder Therapeutics Drugs Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Bipolar Disorder Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Bipolar Disorder Therapeutics Drugs Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Bipolar Disorder Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Bipolar Disorder Therapeutics Drugs Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Bipolar Disorder Therapeutics Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Bipolar Disorder Therapeutics Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Bipolar Disorder Therapeutics Drugs in the World: Market Share by Bipolar Disorder Therapeutics Drugs Revenue in 2021
Figure 31. Global Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 33. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 34. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 35. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 36. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 38. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 39. North America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 40. North America Bipolar Disorder Therapeutics Drugs Sales Share by Country (2017-2028)
Figure 41. North America Bipolar Disorder Therapeutics Drugs Revenue Share by Country (2017-2028)
Figure 42. U.S. Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 45. Europe Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 46. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 47. Europe Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 48. Europe Bipolar Disorder Therapeutics Drugs Sales Share by Country (2017-2028)
Figure 49. Europe Bipolar Disorder Therapeutics Drugs Revenue Share by Country (2017-2028)
Figure 50. Germany Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 51. France Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue Share by Region (2017-2028)
Figure 61. China Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. India Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 72. Latin America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 74. Latin America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Bipolar Disorder Therapeutics Drugs Sales Share by Country (2017-2028)
Figure 76. Latin America Bipolar Disorder Therapeutics Drugs Revenue Share by Country (2017-2028)
Figure 77. Mexico Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue Share by Country (2017-2028)
Figure 86. Turkey Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 88. U.A.E Bipolar Disorder Therapeutics Drugs Revenue (2017-2028) & (US$ Million)
Figure 89. Bipolar Disorder Therapeutics Drugs Value Chain
Figure 90. Bipolar Disorder Therapeutics Drugs Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
